Richard Burr: “How many lives need to be at risk before this is a medical problem?”

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

I will tell you right now, Congress is going to require accountability in the new program.

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

Nobody has worked harder on this issue, I think, on the Hill than I have.